#eprtalks search results

As part of the agreement, @bmsnews is responsible for development and commercialisation of the novel antibodies and related products. #biologics #EPRtalks europeanpharmaceuticalreview.com/news/240639/br…

@novonordisk's production facility will utilise advanced technology and innovative equipment to meet growing global demand #pharmaceuticalmanufacturing #EPRtalks europeanpharmaceuticalreview.com/news/240371/no…

"Approval by the [European Commission] is significant because Elahere is the first new medication approved specifically for platinum-resistant ovarian cancer since 2014". #pharma #EPRTalks europeanpharmaceuticalreview.com/article/240018…

"These reforms protect the safe development of pioneering new treatments," Dr June Raine, @MHRAgovuk Chief Executive stated. #EPRTalks europeanpharmaceuticalreview.com/news/240039/le…

“By combining our expertise in #clinicaltrials and #lifesciences with world-class researchers, we can accelerate the development of groundbreaking treatments that will benefit patients across [the UK and Switzerland]” says UK Health Minister. #EPRTalks europeanpharmaceuticalreview.com/news/239768/16…

The new appointments by @Amgen and @pfizer will drive development of new medicines across numerous therapeutic areas such as rare disease and cancer. europeanpharmaceuticalreview.com/news/237695/am… #EPRTalks

Investment in @sanofi's Lyon Gerland site will aid internal bioproduction of a type 1 #diabetes drug, enabling market availability in 2027. europeanpharmaceuticalreview.com/news/237061/sa… #pharmaceuticalmanfacturing #EPRTalks

As part of the acquisition, @BioNTech_Group will gain rights to a state-of-the-art biologics manufacturing facility. europeanpharmaceuticalreview.com/news/236460/bi… #biologics #EPRTalks

@AstraZeneca's recent US investment is part of the company's plan to secure $80 billion in Total Revenue by the end of 2030. #Pharmaceutical #EPRTalks europeanpharmaceuticalreview.com/news/236075/ne…

A key benefit of the film bag “is its simplicity because no equipment for mechanical aeration is required”. #microbiology #EPRTalks europeanpharmaceuticalreview.com/news/235696/in…

The project has potential "to develop the next generation AAV platform which could potentially help to unlock a cost-effective manufacturing option for higher dose or systemic applications.” #genetherapy #EPRTalks europeanpharmaceuticalreview.com/news/235000/aa…

A Phase III trial showed the haemophilia treatment reduced the annualised bleeding rate for treated bleeds by 35 percent and 92 percent after 12 months of active treatment. #ClinicalTrials #EPRTalks europeanpharmaceuticalreview.com/news/234966/ha…

@ferring's new facility in Finland “marks an important milestone in ensuring stable and sustainable global supply of Adstiladrin® to meet the anticipated growth in demand" #EPRTalks europeanpharmaceuticalreview.com/news/234639/eu…

"RGT-419B is the only CDK4 inhibitor with single agent efficacy in refractory ER+/HER2- breast cancer” @genentech #EPRTalks europeanpharmaceuticalreview.com/news/234590/ge…

“Nearly 80 percent of patients in our study were progression-free after six months". #clinicaltrials #EPRTalks europeanpharmaceuticalreview.com/news/234471/ra…

The treatment uses a novel target to manage symptoms of schizophrenia, such as hallucinations. @US_FDA #regulation #EPRTalks europeanpharmaceuticalreview.com/news/234077/fi…

The new guidance seeks to "improve the diversity of trial participants to ensure research benefits the broadest range of people", says @WHO’s Chief Scientist. #EPRTalks europeanpharmaceuticalreview.com/news/234004/wh…

Currently, "there is a big unmet need for drugs that specifically target sepsis" according to GlobalData #WorldSepsisDay #EPRTalks sepsishttps://www.europeanpharmaceuticalreview.com/news/233665/sepsis-addressing-unmet-needs-for-a-global-priority/

@EliLillyandCo's new investment brings the company's total financing for its Limerick site to $2 billion. #pharmaceuticalmanufacturing #EPRTalks europeanpharmaceuticalreview.com/news/233616/li…

The building, supported by a nearly €500 million investment, is modular by design and contains "the equivalent of 34 standardised mini-factories". @Sanofi #EPRTalks europeanpharmaceuticalreview.com/news/233574/in…

A new formulation of an antibody drug has been authorised via a process from the MHRA that enables “considerably shorter” approval timelines in the E.U. #formulation #regulatory #EPRTalks @DNC @BernieSanders @SenWarren @SpeakerJohnson @ClevelandClinic @MayoClinic @MGHGlobalHealth

Supercritical fluid chromatography is becoming a “dominant” technique for enantiomeric separation, especially purification, the paper stated. #analyticaltechniques #pharmaceutical #EPRTalks

The UK industry body has invited proposals on economic investment, support for #pharmaceuticalmanufacturing, clinical trials and R&D. #EPRTalks

According to Gilead, the study is the first Phase III #HIV prevention trial to demonstrate a zero-infection rate. #clinicaltrials #EPRTalks

Fifty four percent of evaluable patients with DLBCL attained a substantial tumour reduction with the five-drug regimen, trial data shows. #oncology #drugdevelopment #EPRTalks

Ocugen's CSO Dr Arun Upadhyay, discusses promising modifier #genetherapy candidates for ophthalmic disorders. #geneticdiseases #EPRTalks

agileregulatory.com/blogs/what-is-… #epr #eprcertification #eprtalks #eprcertificate #eprlicense #eprregistration #eprauthorization #eprforewaste #eprforplasticwaste #eprforbattery #cpcb #ewaste #ewasterecycling #ewastemanagement #plasticwaste #plasticwastemanagement

Currently, the Latina site exports 97 per cent of the medicine it produces, according to Johnson & Johnson. #pharmaceuticalmanufacturing #supplychain #EPRTalks

SMA patients in the long-term extension Evrysdi study maintained or improved key developmental skills over the five-year period, data shows. #clinicaltrials #raredisease #EPRTalks

In this article, Johnson & Johnson's EMEA haematology medical affairs lead discusses cell therapies and biologics in multiple myeloma. #biologics #celltherapy #EPRTalks

To enhance #Pharma #sustainability, EFPIA strives “to go beyond compliance on the targets set within the various EU legislative requirements”. #EPRTalks

Find out how #drugdelivery is evolving to increase focus on #sustainability through development of long-acting, oral-delivery technologies. #EPRTalks

Is the pharmaceutical industry ready for digital innovations like AI, and are these advances are a threat or ally to IP rights. #regulatory #AI #EPRTalks

The microparticle-based drug formulation offers a new delivery approach which could improve patient compliance, the paper stated. #drugdelivery #formulation #EPRTalks

The FDA’s approval of the telomerase inhibitor is welcome, considering the high unmet need for many LR-MDS patients, according to Geron. #regulatory #bloodcancer #EPRTalks

The new approval of the anti-PD-1 combination therapy is indicated for certain patients with the most common gynaecologic cancer, MSD states. #regulatory #immunotherapy #EPRTalks

Once-weekly or once-monthly dosing offers flexibility in haemophilia A with or without inhibitors, stated Novo Nordisk’s EVP for Development. #raredisease #clinicaltrials #EPRTalks

Following advancements at a similar European facility, the new US manufacturing facility is set to produce lead-212 radioligand therapies. #radiotherapeutics #pharmaceuticalmanufacturing #EPRTalks

These data from the trial could lead to clinically meaningful benefits for #cardiovascular, renal, and metabolic diseases, Boehringer says. #clinicaltrials #EPRTalks

Balancing safety, efficacy and cost in drug development is challenging. Prodrugs offer potential solutions, but also introduce additional complexities, as Dave Elder explains. #drugdevelopment #pharma #EPRTalks